Shanghai Fosun Pharmaceutical

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a unit of one of China’s largest conglomerates Fosun International. Already listed in Shanghai, the group plans to raise about US$512 million through an initial public offering in November 2012, and said it would use about half the proceeds for domestic and international acquisitions, and the rest for research and development and to pay down debt.

Fosun Pharma unveils plan to battle cancer with early diagnosis and cost-effective treatment options

Fosun Pharma pivots towards cancer diagnosis, treatment

Fosun Pharmaceutical, a leading healthcare group on the mainland, plans to focus on early diagnosis and cost-effective treatment of cancer by using the world’s latest technologies such as robotic-assisted medical devices.